» Articles » PMID: 36627703

GSDMD-mediated Pyroptosis Dominantly Promotes Left Ventricular Remodeling and Dysfunction in Post-myocardial Infarction: a Comparison Across Modes of Programmed Cell Death and Mitochondrial Involvement

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Jan 10
PMID 36627703
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myocardial infarction (MI) has recently accounted for more than one-third of global mortality. Multiple molecular pathological pathways, such as oxidative stress, inflammation, and mitochondrial dysfunction, have been recognized as possible mechanisms in the development of MI. Furthermore, different phases of ischemic injury following the progression of MI were also associated with multiple types of programmed cell death (PCDs), including apoptosis, necroptosis, ferroptosis, and pyroptosis. However, it remains unknown whether which types of PCDs play the most dominant role in post-myocardial infarction (post-MI).

Method: In this study, we used a preclinical rat model of MI induced by permanent left anterior descending coronary artery (LAD) ligation (n = 6) or a sham operated rat model (n = 6). After a 5-week experiment, cardiac function and morphology, mitochondrial studies, and molecular signaling analysis of PCDs were determined.

Results: Herein, we demonstrated that post-MI rats had considerably impaired cardiac geometry, increased oxidative stress, myocardial injuries, and subsequently contractile dysfunction. They also exhibited worsened cardiac mitochondrial function and dynamic imbalance. More importantly, we found that post-MI mediated abundant myocardial cell death through multiple PCDs, including apoptosis, necroptosis, and pyroptosis, but not ferroptosis.

Conclusion: In this study, we provide the first insights into the mechanism of PCDs by pyroptosis, which is leveraged as the most dominant mode of cell death after MI.

Citing Articles

Therapeutic Potential of Gasdermin D-Mediated Myocardial Pyroptosis in Ischaemic Heart Disease: Expanding the Paradigm From Bench to Clinical Insights.

Piamsiri C, Maneechote C, Chattipakorn S, Chattipakorn N J Cell Mol Med. 2025; 29(3):e70357.

PMID: 39929748 PMC: 11810530. DOI: 10.1111/jcmm.70357.


Unraveling the AMPK-SIRT1-FOXO Pathway: The In-Depth Analysis and Breakthrough Prospects of Oxidative Stress-Induced Diseases.

Guan G, Chen Y, Dong Y Antioxidants (Basel). 2025; 14(1).

PMID: 39857404 PMC: 11763278. DOI: 10.3390/antiox14010070.


Programmed cardiomyocyte death in myocardial infarction.

Wu H, Lan Q, He Y, Xue J, Liu H, Zou Y Apoptosis. 2025; .

PMID: 39833636 DOI: 10.1007/s10495-025-02075-3.


Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner.

Ge W, Zhang X, Lin J, Wang Y, Zhang X, Duan Y Cell Death Dis. 2025; 16(1):2.

PMID: 39755713 PMC: 11700182. DOI: 10.1038/s41419-024-07322-0.


The Potential Therapeutic Prospect of PANoptosis in Heart Failure.

Jia Y, Liu Y, Zuo Y, Zhang J, Li Y, Liu X J Inflamm Res. 2024; 17:9147-9168.

PMID: 39583864 PMC: 11585275. DOI: 10.2147/JIR.S485901.


References
1.
Placer Z, Cushman L, Johnson B . Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem. 1966; 16(2):359-64. DOI: 10.1016/0003-2697(66)90167-9. View

2.
Maneechote C, Palee S, Kerdphoo S, Jaiwongkam T, Chattipakorn S, Chattipakorn N . Modulating mitochondrial dynamics attenuates cardiac ischemia-reperfusion injury in prediabetic rats. Acta Pharmacol Sin. 2021; 43(1):26-38. PMC: 8724282. DOI: 10.1038/s41401-021-00626-3. View

3.
Zhang H, Yin Y, Liu Y, Zou G, Huang H, Qian P . Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction. Biochem Pharmacol. 2020; 175:113915. DOI: 10.1016/j.bcp.2020.113915. View

4.
Pasparakis M, Vandenabeele P . Necroptosis and its role in inflammation. Nature. 2015; 517(7534):311-20. DOI: 10.1038/nature14191. View

5.
Siasos G, Tsigkou V, Kosmopoulos M, Theodosiadis D, Simantiris S, Tagkou N . Mitochondria and cardiovascular diseases-from pathophysiology to treatment. Ann Transl Med. 2018; 6(12):256. PMC: 6046286. DOI: 10.21037/atm.2018.06.21. View